Practical Considerations for Cell and Gene Therapy Trials

This white paper outlines practical considerations for conducting cell and gene therapy (CGT) trials in neonates and young children with rare diseases. It discusses the potential of CGT as a curative treatment option, emphasizing the importance of ethical considerations, informed consent, and the long-term commitment required from families participating in these trials. The paper details operational challenges faced in pediatric CGT studies, including the need for careful planning, site feasibility, and the importance of supporting families throughout the trial process. Key factors such as early intervention, disease progression, and the efficacy of treatments are highlighted as critical to the success of these trials. Additionally, the document addresses the necessity of robust training materials for caregivers, the significance of building relationships with clinical sites, and the importance of ongoing support to minimize burdens on families. Overall, the paper aims to provide actionable guidance for stakeholders involved in pediatric CGT trials.